The CMS announced a new model to give Part D plans more skin in the game to cut Medicare's drug spending, and will expand the scope of its Medicare Advantage value-based design model.
The Medicare Payment Advisory Commission recommended that Congress pass legislation to consolidate most of Medicare's value-based quality programs and boost payments for high-performing hospitals.
A proposal from Sen. Marco Rubio (R-Fla.) to redistribute DSH money more equitably among states has a short runway to get congressional support ahead of a key September deadline. Can it get there?
Hundreds of groups including major healthcare industry associations and hospitals sent letters to Congress and President Donald Trump urging an end to the partial government shutdown, citing health consequences of the lapsed funding.
Since it was enacted in 1997, the Children's Health Insurance Program has been largely hailed as a success and enjoyed support from both sides of the political aisle. While it got caught up in partisan bickering in late 2017, CHIP was ultimately reauthorized through 2023.
Dr. David Shulkin, whose departure from the VA was announced through Twitter this past spring, will be chief innovation officer at Sanford Health in South Dakota.
The Food and Drug Administration is preparing to allow the over-the-counter purchase of the drug overdose-reversal medication naloxone in an effort to expand greater access to the lifesaving drug.
North Carolina's attorney general approved hospital giant HCA Healthcare's $1.5 billion acquisition of Asheville-based Mission Health, after nabbing commitments from HCA meant to protect the state's healthcare industry.
White House budget officials are weighing draft regulations to shape the VA's new, streamlined community care program that is poised to bring billions into private hospitals and clinics.